|
|
||||||||
1 From the National Research Center for Environment and Health (GSF), Institute of Mammalian Genetics, Neuherberg, Germany.
| Abstract |
|---|
|
|
|---|
METHODS. Native lenses were photographed under a dissecting microscope. Histologic sections of the eye were made according to standard procedures. Fine mapping of the mutation in relation to microsatellite markers for mouse chromosome 1 was performed. Candidate genes were amplified by PCR from cDNA or genomic DNA and sequenced.
RESULTS. The nuclear opacity of the heterozygous mutants showed radial structures, whereas the opacity of the homozygotes was homogenous. The histologic analysis revealed changes in the lens nucleus, which corresponds to the pronounced opacification in lenses of homozygous mutants. The allelism of Rop to the Cat2 group of dominant cataracts on mouse chromosome 1 was confirmed by linkage to microsatellite markers D1Mit156 and D1Mit181. The cluster of the Cryg genes and the closely linked Cryba2 gene were tested as candidates. A T
A exchange in exon 2 of the Crygf gene leads to a Val
Glu exchange in codon 38 and was considered to be causative for the cataract phenotype; therefore, CrygfRop has been suggested as the designation for the mutation.
CONCLUSIONS. CrygfRop is the first mutation affecting the Crygf gene. Dominant cataract mutations for all six Cryg genes on mouse chromosome 1 have now been characterized, demonstrating the importance of this gene cluster in lens transparency.
| Introduction |
|---|
|
|
|---|
-, ß-, and
-crystallins are a major protein component of the lens and are considered essential for lens transparency. The family of
-crystallin encoding genes (Cryg) consists of seven highly homologous genes: Six (Cryga Crygf) are located in a tight cluster on mouse chromosome 1 (human chromosome 2q33-35) and the seventh (Crygs) is on mouse chromosome 16 (human chromosome 3).1
2
3
Crystallographic analyses have shown that the
-crystallins are composed of two domains, each consisting of two Greek key motifs. The Cryg genes in all mammals consist of three exons: exon 1 codes only for three amino acids, and exons 2 and 3 each encode two Greek key motifs. Biochemically, the
-crystallins are monomers with a molecular mass of 21 kDa.2
3
4
Up to now, several types of hereditary cataracts in humans have been shown to be caused by mutations in CRYG genes.5 6 7 8 9 In humans two of the six CRYG genes are pseudogenes (CRYGE and CRYGF) that are not expressed, because of several mutations in their promoters.1 5 10 In the mouse, all seven Cryg genes are expressed in the lens.
Several mouse mutations in the Cryg genes leading to cataracts have been identified: CrygaENU436, CrygbNop,11 CrygcChl3,12 CrygdLop12,13 and CrygdAey4.14 For the Cryge gene, five cataract alleles have been reported so far: CrygeElo,15 Cryget,11 Crygens,16 Crygenz,17 and CrygeAey1.18 Just recently, a temperature-sensitive mutation of the Crygs gene, CrygsOpj, was characterized in the mouse.19 However, to date, no mutation has been detected in the Crygf gene.
A mutation, previously designated as Rop (radial opacity), was found by ophthalmic screening of mice after paternal treatment with procarbazine.20 Rop has been shown to be allelic or tightly linked with a group of cataract mutations on mouse chromosome 1,21 and some of these mutations have been identified as mutant alleles of different Cryg genes.11 17 Based on chromosome location and lens phenotype, the six genes (Cryga Crygf) of the Cryg gene cluster, as well as the closely linked Cryba2 gene, were considered to be good candidates for Rop mutation analysis. Results revealed that the Rop mutation is associated with a sequence alteration of the Crygf gene. This report describes the molecular lesion and provides morphologic data on Rop mutants.
| Materials and Methods |
|---|
|
|
|---|
Morphologic Analysis
For gross observation, mice at different ages (ranging from 2 weeks to 3 months) were killed and the eyes dissected. The lenses were enucleated under a dissecting microscope (MZ APO; Leica, Bensheim, Germany) and photographed at x20 magnification. For histologic analysis, eyes from 4-day-old mice were fixed for 24 hours in Carnoy solution, dehydrated, and embedded in plastic medium (JB-4Plus; Polysciences Inc., Eppelheim, Germany), according to the manufacturers instructions. Sectioning was performed with an ultramicrotome (Ultratom OMU3; Reichert, Walldorf, Germany). Serial transverse 2-µm sections were cut with a dry glass knife and stained with methylene blue and basic fuchsin. The sections were evaluated by light microscope (Axioplan; Carl Zeiss, Hallbergmoos, Germany). Images were acquired by means of a scanning camera equipped with a screen-capture program (Axiocam and Axiovision; Carl Zeiss) and imported into an image-processing program (Photoshop, ver. 6.0; Adobe Illustrator 9.0, Adobe Systems, Unterschleissheim, Germany).
Fine Mapping of the Rop Mutation
For fine mapping of the Rop mutation, linkage was tested in relation to the markers D1Mit156 and D1Mit181 in the cross (C3HRop x C57BL/6)F1 x C57BL/6.
Isolation of RNA, DNA, and PCR Conditions
Genomic DNA was prepared from spleen or tail tips of 3-week-old mice according to standard procedures. RNA was isolated from lenses (stored at 80°C) of newborn mice. cDNA synthesis and PCR using genomic DNA or cDNA as a template were performed essentially as reported previously.11
Because Crygf cDNA is difficult to amplify because of its similarity to and the predominance of Cryge, it was amplified from genomic DNA using a primer pair for exons 1 and 2, together with their flanking regions and the connecting intron A (forward: 5'-GTT ATT CAA ATT CTC TTA GTG TGA GAA TTA TAA ACC-3'; reverse: 5'-ACA AAG AAG GTA GCA GAT ATC CTA ACC-3'; annealing temperature 58°C) and for exon 3 (forward 5'-AAA CAC ACA GGA AAT ATT TTA CTG TCC-3' and reverse 5'-GAT GTC CCC TTG TCT GCT GTT C-3'; annealing temperature 4849°C). Besides the Cryg genes, the closely linked Cryba2 (GenBank/EMBL accession number NM_021541; GenBank is provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD, and is available at http://www.ncbi.nlm.nih.gov/Genbank; EMBL is provided in the public domain by the European Molecular Biology Laboratory, Heidelberg, Germany, and is available at http://www.embl-heidelberg.de) was tested as a candidate as described recently.18
PCR products were sequenced commercially (SequiServe, Vaterstetten, Germany) either after cloning into the pCR2.1 vector (Invitrogen, Leek, The Netherlands) or directly after elution from the agarose gel, with kits from Qiagen (Hilden, Germany) or Bio-Rad (Munich, Germany) and subsequent precipitation by ethanol and glycogen. MnlI digested PCR fragments were analyzed in a 10% polyacrylamide gel.
General
Chemicals were from Merck (Darmstadt, Germany) or Sigma Chemical Co. (Deisenhofen, Germany). The enzymes used for cloning and reverse transcription were from Roche Diagnostics (Mannheim, Germany), and restriction enzymes were from MBI Fermentas (St. Leon-Rot, Germany), if not otherwise mentioned.
| Result |
|---|
|
|
|---|
|
|
The Cryba2 gene and all six members of the Cryg gene cluster were amplified and sequenced. No difference was found between the wild types and the Rop mutants in the Cryga, Crygb, Crygc, Crygd, Cryge, and Cryba2 cDNA or genomic DNA. In the Cryg genes, some polymorphic sites were discovered in the Rop mutant and the wild types, as described previously.18
The only DNA sequence difference between wild-type C3H and mutant Rop, which leads to an alteration of the amino acid sequence, was identified in the Crygf gene (GenBank accession number, M11039) as a T
A exchange at position 113 of the cDNA (Fig. 3)
. The mutation creates a new MnlI restriction site. This new MnlI restriction site was only present in the genomic DNA of the mutants (as demonstrated for four different homozygotes), but it was always absent in wild-type mice, as demonstrated for four different strains (Fig. 4)
. Therefore, we concluded that this point mutation in the Crygf gene is responsible for the cataractous phenotype; the suggested new allele symbol is CrygfRop.
|
|
-crystallins analyzed (human, mouse, rat, bovine). Moreover, the exchange of this hydrophobic, neutral Val residue at position 38 by the charged, acidic Glu leads to a clear decrease of the isoelectric point (pI) from pH 7.1 in the wild type to pH 6.7 in the mutants. If the pI is calculated only for the short decapeptide demonstrated in Figure 3
, the decrease of the pI in this microenvironment is more than 1 pH unit (from pH 5.8 to 4.4). However, the highly conserved Val residue, which occupies a buried environment in the wild type, is changed to a bulkier, charged Glu residue, suggesting the protein to be in an unfolded, precipitated stage that affects in particular the first Greek key motif, which is defined between amino acid positions 3 and 39.22 | Discussion |
|---|
|
|
|---|
The CrygfRop point mutation causes an amino acid exchange of Val to Glu in the first Greek key motif. This Val is highly conserved in all mammalian
-crystallins, and its alteration may disturb the folding characteristic of the
F-crystallin. Unfortunately, it is not possible to test specifically whether the altered protein is expressed in the lens. However, for all other mouse Cryg cataract mutations, for which the mutant gene product could be specifically assayed by Western blot analysis, there was stable expression of the corresponding protein.11
17
18
Dramatic changes in the biophysical properties of the altered protein are indicated by the decrease of the overall pI of the mutant protein by approximately a half pH unit or by the decrease by 1.5 pH units in the microenvironment of the altered amino acid.
The CrygfRop mutation is the first mutation in the mouse Crygf gene, but the 10th mutation identified in the Cryg gene cluster. Thus, we have characterized the Cryga1Neu, Crygbnop, CrygcChl3, CrygdAey4, CrygeAey1, Crygens, Crygenz, and Cryget11 12 14 16 17 18 ; the CrygdLop12 and the Crygeelo have been reported by others.13 15 The CrygfRop heterozygotes express a radial opacity. This resulting phenotype is unique among the numerous mutants maintained in the collection of the genetic institutes at Neuherberg.
Currently, also in humans, an increasing number of mutations in the CRYG genes has been found to lead to cataract formation: the Coppock-like cataract and a variable zonular pulverulent cataract in the presence of the CRYGC gene and an aculeiform cataract, a punctate cataract, and a crystal cataract in the presence of CRYGD.5 6 7 8 9 Moreover, a polymorphic congenital cataract has been mapped very close to the CRYGB gene.24
From the high frequency of cataracts with different clinical phenotypes associated with mutations affecting one of the Cryg genes, it can be concluded that the Cryg gene cluster is very important for the maintenance of lens transparency. All Cryg mutations reported so far are dominant or semidominant, and all lead to structural alterations of the proteins. Neither gene deletions nor recessive mutations in the
-crystallin encoding genes have yet been described.
In the context of the first mouse Crygf mutation, the CRYGE and CRYGF genes in humans are pseudogenes. Among the 10 mouse mutations in the Cryg genes, a relatively high number (50%) affect the Cryge gene and one affects the Crygf gene. Therefore, specific gene functions must be elaborated for the individual members of the Cryg gene cluster. Such studies may explain the specific differences in the frequencies of the gene mutations and the loss of the CRYGE and CRYGF gene expression in humans compared with the mouse. Nevertheless, the existing data suggest that the consequences of expressed altered proteins may be more complicated ("dominant negative") than the loss of the corresponding gene function, as indicated by the two CRYG pseudogenes in humans.
| Acknowledgements |
|---|
| Footnotes |
|---|
3 GSF, Institute of Human Genetics, Neuherberg, Germany. ![]()
Submitted for publication March 1, 2002; revised April 29, 2002; accepted May 29, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Jochen Graw, GSF-National Research Center for Environment and Health, Institute of Mammalian Genetics, Ingolstädter Landstr. 1, D-85764 Neuherberg, Germany; graw{at}gsf.de.
| References |
|---|
|
|
|---|
-crystallin genes: a gene family on its way to extinction J Mol Biol 216,519-532[Medline][Order article via Infotrieve]
-crystallins and human cataracts: a puzzle made clearer Am J Hum Genet 65,1261-1267[Medline][Order article via Infotrieve]
D-crystallin gene Proc Natl Acad Sci USA 96,1008-1012
C-crystallin gene is associated with autosomal dominant variable zonular pulverulent cataract Hum Genet 106,531-537[Medline][Order article via Infotrieve]
D-crystallin allele and a unique cataract phenotype explained by protein crystallography Hum Mol Genet 9,1779-1786
-crystallin genes cause autosomal dominant congenital cataracts J Med Genet 39,352-358
-crystallin gene family Mol Cell Biol 5,1408-1414
-crystallin genes Genomics 52,152-158[Medline][Order article via Infotrieve]
D-crystallin region leads to dominant cataracts in mice Mamm Genome In press
E-crystallin gene of the Elo mouse Nat Genet 2,42-45[Medline][Order article via Infotrieve]
E-crystallin gene leading to a nuclear and zonular cataract in the mouse Invest Ophthalmol Vis Sci 42,183-187
S-crystallin based on ß- and
-crystallin X-ray coordinates and ultracentrifugation Protein Sci 3,1840-1846[Medline][Order article via Infotrieve]
-crystallin gene locus on human chromosome 2q33-35 Hum Mol Genet 5,699-703This article has been cited by other articles:
![]() |
K. L. Moreau and J. King Hydrophobic Core Mutations Associated with Cataract Development in Mice Destabilize Human {gamma}D-Crystallin J. Biol. Chem., November 27, 2009; 284(48): 33285 - 33295. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Graw, A. Neuhauser-Klaus, N. Klopp, P. B. Selby, J. Loster, and J. Favor Genetic and Allelic Heterogeneity of Cryg Mutations in Eight Distinct Forms of Dominant Cataract in the Mouse Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1202 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fan, A. K. Donovan, D. R. Ledee, P. S. Zelenka, R. N. Fariss, and A. B. Chepelinsky {gamma}E-crystallin Recruitment to the Plasma Membrane by Specific Interaction between Lens MIP/Aquaporin-0 and {gamma}E-crystallin Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 863 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Nandrot, C Slingsby, A Basak, M Cherif-Chefchaouni, B Benazzouz, Y Hajaji, S Boutayeb, O Gribouval, L Arbogast, A Berraho, et al. Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts J. Med. Genet., April 1, 2003; 40(4): 262 - 267. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |